FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Toni Shippenberg

Research Profile

Living Beings

Chemicals & Drugs

Activities & Behaviors

Physiology

Conditioning, Operant

Co-author Network

Publications

TOP 3
Shaaban A Mousa; Jan F Richter; Laura Schaad; Jonas Schneider; Mehdi Shakibaei; Mohammed Shaqura; Toni S Shippenberg; Christian Zöllner; Rainer Hellweg; Baled I Khalefa; Michael Schäfer
Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.
Agustin Zapata; M Alba Abad; Cristina M Bäckman; Marta Enguita; Eric Oh; Silvia Pontis; Raf J Schepers; Alexandra Stein; Ramon Trullas; Ruizhong Wang; Paul Worley; Toni S Shippenberg
Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla.
Murat Oz; Georg Petroianu; Muhammed Hasan; Dmytro Isaev; Dietrich E Lorke; Toni S Shippenberg
Methylene blue inhibits function of the 5-HT transporter.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Toni Shippenberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shaaban A Mousa; Jan F Richter; Laura Schaad; Jonas Schneider; Mehdi Shakibaei; Mohammed Shaqura; Toni S Shippenberg; Christian Zöllner; Rainer Hellweg; Baled I Khalefa; Michael Schäfer
Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.
Diabetes 2013;62(4):1308-19.
2012: Agustin Zapata; M Alba Abad; Cristina M Bäckman; Marta Enguita; Eric Oh; Silvia Pontis; Raf J Schepers; Alexandra Stein; Ramon Trullas; Ruizhong Wang; Paul Worley; Toni S Shippenberg
Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(36):12431-6.
2012: Murat Oz; Georg Petroianu; Muhammed Hasan; Dmytro Isaev; Dietrich E Lorke; Toni S Shippenberg
Methylene blue inhibits function of the 5-HT transporter.
British journal of pharmacology 2012;166(1):168-76.
2011: Elena E Bagley; Vladimir I Chefer; Billy C H Chieng; Jennifer Hacker; Christophe Mallet; Gavan P McNally; Julie Perroud; Toni S Shippenberg; MacDonald J Christie
Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors.
Nature neuroscience 2011;14(12):1548-54.
2011: Vladimir Chefer; Ruizhong Wang; Toni S Shippenberg
Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(10):2018-29.
2011: Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Toni S Shippenberg; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.
The Journal of biological chemistry 2011;286(23):20239-50.
2011: Cameron H Good; Alexander F Hoffman; Barry J Hoffer; Vladimir I Chefer; Toni S Shippenberg; Cristina M Bäckman; Nils-Göran Larsson; Lars Olson; Sandra Gellhaar; Dagmar Galter; Carl R Lupica
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(4):1333-44.
2011: Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Regulation of monoamine transporters: Role of transporter phosphorylation.
Pharmacology & therapeutics 2011;129(2):220-38.
2011: Rafal M Kaminski; Juan F Núñez-Taltavull; Boguslawa Budziszewska; Władysław Lasoń; Maciej Gasior; Agustin Zapata; Toni S Shippenberg; Jeffrey M Witkin
Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain.
Neurochemical research 2011;36(1):146-52.
2010: Agustin Zapata; Vicki L Minney; Toni S Shippenberg
Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(46):15457-63.
2010: Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(43):14502-12.
2010: Murat Oz; Therissa Libby; Bronwyn Kivell; Vanaja Jaligam; Sammanda Ramamoorthy; Toni S Shippenberg
Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+.
Journal of neurochemistry 2010;114(4):1019-29.
2010: Hugo A Tejeda; Vladimir Chefer; Agustin Zapata; Toni S Shippenberg
The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
Psychopharmacology 2010;210(2):231-40.
2010: Keun-Hang Yang; Sehamuddin Galadari; Dmytro Isaev; Georg Petroianu; Toni S Shippenberg; Murat Oz
The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
The Journal of pharmacology and experimental therapeutics 2010;333(2):547-54.
2010: Murat Oz; Vanaja Jaligam; Sehamuddin Galadari; George Petroianu; Yaroslav M Shuba; Toni S Shippenberg
The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.
Journal of neurochemistry 2010;112(6):1454-64.
2009: Tommaso Cassano; Silvana Gaetani; Maria Grazia Morgese; Teresa Macheda; Leonardo Laconca; Pasqua Dipasquale; Juan Taltavull; Toni S Shippenberg; Vincenzo Cuomo; Gabriella Gobbi
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.
Neurochemical research 2009;34(8):1417-26.
2009: Vladimir Chefer; Luc Denoroy; Agustin Zapata; Toni S Shippenberg
Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.
The European journal of neuroscience 2009;30(2):272-8.
2009: Agustin Zapata; Vladimir Chefer; Toni S Shippenberg; Luc Denoroy
Detection and quantification of neurotransmitters in dialysates.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2009;Chapter 7():Unit 7.4.1-30.
2009: Agustin Zapata; Vladimir I Chefer; Toni S Shippenberg
Microdialysis in rodents.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2009;Chapter 7():Unit7.2.
2009: Vladimir I Chefer; AC Thompson; Agustin Zapata; Toni S Shippenberg
Overview of brain microdialysis.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2009;Chapter 7():Unit7.1.
2009: Vladimir Chefer; Toni S Shippenberg
Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(4):887-98.
2009: Toni S Shippenberg; Vladimir I Chefer; Alexis C Thompson
Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.
Biological psychiatry 2009;65(2):169-74.
2008: Toni S Shippenberg; A LeFevour; Vladimir Chefer
Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.
CNS & neurological disorders drug targets 2008;7(5):442-53.
2008: R J Schepers; Janet Lynn Mahoney; Brenda Jean Gehrke; Toni S Shippenberg
Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation.
Pain 2008;138(2):423-39.
2008: Raf Jan-Filip Schepers; Janet Lynn Mahoney; Toni S Shippenberg
Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception.
Pain 2008;136(3):320-30.
2008: Brenda J Gehrke; Vladimir Chefer; Toni S Shippenberg
Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.
Psychopharmacology 2008;197(3):509-17.
2008: Shelley N Jackson; Sachin K Singhal; Amina S Woods; Marisela Morales; Toni S Shippenberg; Li Zhang; Murat Oz
Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes.
European journal of pharmacology 2008;582(1-3):42-51.
2008: Raf Jan-Filip Schepers; Janet Lynn Mahoney; Agustin Zapata; Vladimir Chefer; Toni S Shippenberg
The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla.
Journal of neurochemistry 2008;104(3):806-17.
2007: Agustin Zapata; Bronwyn Kivell; Yang Han; Jonathan A Javitch; Elizabeth A Bolan; David Kuraguntla; Vanaja Jaligam; Murat Oz; Lankupalle D Jayanthi; Devadoss J Samuvel; Sammanda Ramamoorthy; Toni S Shippenberg
Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.
The Journal of biological chemistry 2007;282(49):35842-54.
2007: Toni S Shippenberg; Agustin Zapata; Vladimir Chefer
Dynorphin and the pathophysiology of drug addiction.
Pharmacology & therapeutics 2007;116(2):306-21.
2007: Murat Oz; Keun-Hang Yang; Meral Dinc; Toni S Shippenberg
The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
The Journal of pharmacology and experimental therapeutics 2007;323(2):547-54.
2007: Murat Oz; Keun-Hang Yang; Toni S Shippenberg; Leo P Renaud; Michael J O'Donovan
Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons.
Journal of neurophysiology 2007;98(3):1108-14.
2007: Elisabeth Barbier; Agustin Zapata; Eric Oh; Qing Liu; Fei Zhu; Ashiwel S Undieh; Toni S Shippenberg; Jia Bei Wang
Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(8):1774-82.
2007: Arthur Charles Riegel; Agustin Zapata; Toni S Shippenberg; Edward D French
The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(7):1558-69.
2007: Elizabeth A Bolan; Bronwyn Kivell; Vanaja Jaligam; Murat Oz; Lankupalle D Jayanthi; Yang Han; Namita Sen; Eneki Urizar; Ivone Gomes; Lakshmi A Devi; Sammanda Ramamoorthy; Jonathan A Javitch; Agustin Zapata; Toni S Shippenberg
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
Molecular pharmacology 2007;71(5):1222-32.
2007: Rafal M Kaminski; Jeffrey M Witkin; Toni S Shippenberg
Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling.
Neuropharmacology 2007;52(3):895-903.
2006: S Bruening; E Oh; Alfred Hetzenauer; S Escobar-Alvarez; Robert I Westphalen; Hugh C Hemmings; Nicolas Singewald; Toni S Shippenberg; Miklos Toth
The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system.
Journal of neurochemistry 2006;99(3):892-9.
2006: Vladimir Chefer; Agustin Zapata; Toni S Shippenberg; Peter M Bungay
Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens.
Journal of neuroscience methods 2006;155(2):187-93.
2006: William M Doyon; Elaina C Howard; Toni S Shippenberg; Rueben A Gonzales
Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.
Neuropharmacology 2006;51(3):487-96.
2006: Amina S Woods; Rafal M Kaminski; Murat Oz; Yun Wang; Kurt F Hauser; Robin Goody; Hay-Yan J Wang; Shelley N Jackson; Peter Zeitz; Karla P Zeitz; Dorota Zolkowska; Raf Schepers; Michael Nold; Jens Danielson; Astrid Gräslund; Vladana Vukojevic; Georgy Bakalkin; Allan Basbaum; Toni S Shippenberg
Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity.
Journal of proteome research 2006;5(4):1017-23.
2006: Agustin Zapata; Toni S Shippenberg
Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol.
Alcoholism, clinical and experimental research 2006;30(4):592-7.
2006: Elyssa B Margolis; Hagar Lock; Vladimir Chefer; Toni S Shippenberg; Gregory O Hjelmstad; Howard Fields
Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):2938-42.
2006: Agustin Zapata; Rueben A Gonzales; Toni S Shippenberg
Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6J and DBA/2J mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(2):396-405.
2006: Vladimir Chefer; Toni S Shippenberg
Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens.
The European journal of neuroscience 2006;23(1):229-38.
2005: Rafal M Kaminski; Toni S Shippenberg; Jeffrey M Witkin; Beatriz A Rocha
Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures.
Neuroscience letters 2005;382(1-2):51-5.
2005: Vladimir Chefer; Traci A Czyzyk; Elizabeth A Bolan; Jose Moron; John E Pintar; Toni S Shippenberg
Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(20):5029-37.
2005: Agustin Zapata; Toni S Shippenberg
Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
Neuropharmacology 2005;48(1):43-50.
2005: Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Pathobiology of dynorphins in trauma and disease.
Frontiers in bioscience : a journal and virtual library 2005;10():216-35.
2004: Murat Oz; Amina S Woods; Toni S Shippenberg; Rafal M Kaminski
Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Synapse (New York, N.Y.) 2004;52(2):84-8.
2004: Murat Oz; Irina Zakharova; Meral Dinc; Toni S Shippenberg
Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Naunyn-Schmiedeberg's archives of pharmacology 2004;369(2):252-9.
2004: Vladimir Chefer; Jerome Becker; Toni S Shippenberg
Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine.
Neuroscience 2004;127(2):497-503.
2003: Vladimir Chefer; Jerome Becker; Toni S Shippenberg
Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.
The European journal of neuroscience 2003;18(7):1915-22.
2003: José A Morón; Irina Zakharova; Jasmine V Ferrer; Gerald A Merrill; Bruce Hope; Eileen M Lafer; Zhi Cheng Lin; Jia Bei Wang; Jonathan A Javitch; Aurelio Galli; Toni S Shippenberg
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(24):8480-8.
2003: J F Taltavull; Vladimir Chefer; Toni S Shippenberg; Eugene A. Kiyatkin
Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim.
Brain research 2003;975(1-2):244-7.
2003: Vladimir Chefer; Irina Zakharova; Toni S Shippenberg
Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):3076-84.
2003: Agustin Zapata; Vladimir Chefer; Robert Ator; Toni S Shippenberg; Beatriz A Rocha
Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice.
The European journal of neuroscience 2003;17(3):590-6.
2002: Jeffrey M Witkin; Maciej Gasior; Christina Schad; Agustin Zapata; Toni S Shippenberg; Theresa Hartman; Barbara Slusher
NAALADase (GCP II) inhibition prevents cocaine-kindled seizures.
Neuropharmacology 2002;43(3):348-56.
2002: Anthony Basile; Irina Fedorova; Agustin Zapata; Xiaoguang Liu; Toni S Shippenberg; Alokesh Duttaroy; Masahisa Yamada; Jürgen Wess
Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(17):11452-7.
2002: Agustin Zapata; Toni S Shippenberg
D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens.
Journal of neurochemistry 2002;81(5):1035-42.
2002: Lucia Carvelli; José A Morón; Kristopher M Kahlig; Jasmine V Ferrer; Namita Sen; James D Lechleiter; L M Fredrik Leeb-Lundberg; Gerald A Merrill; Eileen M Lafer; Lisa M Ballou; Toni S Shippenberg; Jonathan A Javitch; Richard Z Lin; Aurelio Galli
PI 3-kinase regulation of dopamine uptake.
Journal of neurochemistry 2002;81(4):859-69.
2002: Taco J De Vries; Toni S Shippenberg
Neural systems underlying opiate addiction.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(9):3321-5.
2002: Lynette Daws; Paul D Callaghan; José A Morón; Kristopher M Kahlig; Toni S Shippenberg; Jonathan A Javitch; Aurelio Galli
Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Biochemical and biophysical research communications 2002;290(5):1545-50.
2002: Vladimir Chefer; Toni S Shippenberg
Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions.
Neuroscience 2002;112(4):907-19.
2001: Agustin Zapata; Jeffrey M Witkin; Toni S Shippenberg
Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.
Neuropharmacology 2001;41(3):351-9.
2001: Toni S Shippenberg; Vladimir Chefer; Agustin Zapata; Christian A Heidbreder
Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.
Annals of the New York Academy of Sciences 2001;937():50-73.
2001: M He; Etienne Sibille; Daniel Benjamin; Miklos Toth; Toni S Shippenberg
Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
Brain research 2001;902(1):11-7.
2001: AC Thompson; Toni S Shippenberg
Microdialysis in rodents.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2001;Chapter 7():Unit7.2.
2001: Toni S Shippenberg; AC Thompson
Overview of microdialysis.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2001;Chapter 7():Unit7.1.
2001: Jeffrey Burgdorf; Brian Knutson; Jaak Panksepp; Toni S Shippenberg
Evaluation of rat ultrasonic vocalizations as predictors of the conditioned aversive effects of drugs.
Psychopharmacology 2001;155(1):35-42.
2001: Susan Schenk; B Partridge; Toni S Shippenberg
Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(4):441-50.
2001: JB Acri; AC Thompson; Toni S Shippenberg
Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Synapse (New York, N.Y.) 2001;39(4):343-50.
2000: AC Thompson; Agustin Zapata; Joseph B Justice; Roxanne A Vaughan; Lawrence G Sharpe; Toni S Shippenberg
Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(24):9333-40.
2000: Toni S Shippenberg; William Rea; Barbara Slusher
Modulation of behavioral sensitization to cocaine by NAALADase inhibition.
Synapse (New York, N.Y.) 2000;38(2):161-6.
2000: Lawrence G Sharpe; NS Pilotte; Toni S Shippenberg; C B Goodman; Edythe D London
Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain.
Synapse (New York, N.Y.) 2000;37(4):292-7.
2000: Susan Schenk; B Partridge; Toni S Shippenberg
Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593.
Psychopharmacology 2000;151(1):85-90.
2000: Toni S Shippenberg; R Hen; M He
Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor.
Journal of neurochemistry 2000;75(1):258-65.
2000: E El Daly; Vladimir Chefer; S Sandill; Toni S Shippenberg
Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593.
Journal of neurochemistry 2000;74(4):1553-62.
2000: M He; Toni S Shippenberg
Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum.
The Journal of pharmacology and experimental therapeutics 2000;293(1):121-7.
2000: Vladimir Chefer; José A Morón; Bruce Hope; William Rea; Toni S Shippenberg
Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
Neuroscience 2000;101(3):619-27.
1999: Toni S Shippenberg; M He; Vladimir Chefer
The use of microdialysis in the mouse: conventional versus quantitative techniques.
Psychopharmacology 1999;147(1):33-4.
1999: L Chen; M He; Etienne Sibille; A Thompson; Zoltan Sarnyai; H Baker; Toni S Shippenberg; Miklos Toth
Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B.
Journal of neurochemistry 1999;73(2):647-55.
1999: Vladimir Chefer; AC Thompson; Toni S Shippenberg
Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex.
Annals of the New York Academy of Sciences 1999;877():803-6.
1999: Susan Schenk; B Partridge; Toni S Shippenberg
U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking.
Psychopharmacology 1999;144(4):339-46.
1999: Jeffrey M Witkin; N Savtchenko; M Mashkovsky; M Beekman; Patrik Munzar; Maciej Gasior; Steven R Goldberg; JT Ungard; J Kim; Toni S Shippenberg; Vladimir Chefer
Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
The Journal of pharmacology and experimental therapeutics 1999;288(3):1298-310.
1998: Sari Izenwasser; JB Acri; Paul M Kunko; Toni S Shippenberg
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Synapse (New York, N.Y.) 1998;30(3):275-83.
1998: Christian A Heidbreder; Susan Schenk; B Partridge; Toni S Shippenberg
Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Synapse (New York, N.Y.) 1998;30(3):255-62.
1998: William Rea; Richard B Rothman; Toni S Shippenberg
Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies.
Synapse (New York, N.Y.) 1998;30(1):107-11.
1998: Taco J De Vries; Alexander R Cools; Toni S Shippenberg
Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization.
Neuroreport 1998;9(8):1763-8.
1998: Richard B Rothman; Gregory I Elmer; Toni S Shippenberg; William Rea; Michael H Baumann
Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
Annals of the New York Academy of Sciences 1998;844():59-74.
1998: Toni S Shippenberg; A LeFevour; AC Thompson
Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.
European journal of pharmacology 1998;345(1):27-34.
1998: Toni S Shippenberg; Gregory I Elmer
The neurobiology of opiate reinforcement.
Critical reviews in neurobiology 1998;12(4):267-303.
1997: Toni S Shippenberg; William Rea
Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists.
Pharmacology, biochemistry, and behavior 1997;57(3):449-55.
1996: M Shoaib; Toni S Shippenberg
Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats.
Psychopharmacology 1996;128(4):343-50.
1996: Christian Heidbreder; Toni S Shippenberg
Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine.
Synapse (New York, N.Y.) 1996;24(2):182-92.
1996: Christian Heidbreder; AC Thompson; Toni S Shippenberg
Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
The Journal of pharmacology and experimental therapeutics 1996;278(2):490-502.
1996: M Funada; C G Schutz; Toni S Shippenberg
Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
European journal of pharmacology 1996;300(1-2):17-24.
1996: Toni S Shippenberg; Christian Heidbreder; A Lefevour
Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics.
European journal of pharmacology 1996;299(1-3):33-9.
1996: Christian Heidbreder; M Shoaib; Toni S Shippenberg
Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine.
European journal of pharmacology 1996;298(3):207-16.
1996: Toni S Shippenberg; A LeFevour; Christian Heidbreder
kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
The Journal of pharmacology and experimental therapeutics 1996;276(2):545-54.
1995: Christian Heidbreder; D Babovic-Vuksanovic; M Shoaib; Toni S Shippenberg
Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
The Journal of pharmacology and experimental therapeutics 1995;275(1):150-63.
1995: Taco J De Vries; D Babovic-Vuksanovic; Gregory I Elmer; Toni S Shippenberg
Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine.
Psychopharmacology 1995;120(4):442-8.
1995: Toni S Shippenberg; Christian Heidbreder
The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.
European journal of pharmacology 1995;280(1):55-61.
1995: Toni S Shippenberg; Christian Heidbreder
Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics.
The Journal of pharmacology and experimental therapeutics 1995;273(2):808-15.
1995: M Shoaib; Rainer Spanagel; Thomas Stoehr; Toni S Shippenberg
Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.
Psychopharmacology 1995;117(2):240-7.
1994: Rainer Spanagel; Osborne Almeida; Toni S Shippenberg
Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
European journal of pharmacology 1994;264(2):157-62.
1994: Christian Heidbreder; Toni S Shippenberg
U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine.
Neuroreport 1994;5(14):1797-800.
1994: Rainer Spanagel; Osborne Almeida; C Bartl; Toni S Shippenberg
Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
Psychopharmacology 1994;115(1-2):121-7.
1993: Christian Heidbreder; Steven R Goldberg; Toni S Shippenberg
Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole.
European journal of pharmacology 1993;243(2):123-7.
1993: Christian Heidbreder; Steven R Goldberg; Toni S Shippenberg
The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.
Brain research 1993;616(1-2):335-8.
1993: Rainer Spanagel; Osborne Almeida; Toni S Shippenberg
Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure.
Synapse (New York, N.Y.) 1993;14(3):243-5.
1993: Rainer Spanagel; Toni S Shippenberg
Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat.
Neuroscience letters 1993;153(2):232-6.
1993: Toni S Shippenberg; R Bals-Kubik; A Herz
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
The Journal of pharmacology and experimental therapeutics 1993;265(1):53-9.
1993: R Bals-Kubik; A Ableitner; A Herz; Toni S Shippenberg
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
The Journal of pharmacology and experimental therapeutics 1993;264(1):489-95.
1992: Toni S Shippenberg; A Herz; Rainer Spanagel; R Bals-Kubik; C Stein
Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates.
Annals of the New York Academy of Sciences 1992;654():347-56.
1992: Rainer Spanagel; A Herz; Toni S Shippenberg
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(6):2046-50.
1992: A Herz; Toni S Shippenberg; R Bals-Kubik; Rainer Spanagel
[Opiate addiction. Pharmacologic and biochemical aspects].
Arzneimittel-Forschung 1992;42(2A):256-9.
1992: F J Ayesta; A Ableitner; M W Emmett-Oglesby; A Herz; Toni S Shippenberg
Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
The Journal of pharmacology and experimental therapeutics 1992;260(1):168-74.
1991: Toni S Shippenberg; A Herz; K Nikolarakis
Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus.
Brain research 1991;563(1-2):209-14.
1991: Rainer Spanagel; A Herz; Toni S Shippenberg
Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis.
European journal of pharmacology 1991;200(2-3):319-24.
1991: Toni S Shippenberg; A Herz
Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
The Journal of pharmacology and experimental therapeutics 1991;256(3):1101-6.
1991: Toni S Shippenberg
Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors.
Neuroscience letters 1991;121(1-2):136-8.
1991: Rainer Spanagel; A Herz; R Bals-Kubik; Toni S Shippenberg
Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens.
Psychopharmacology 1991;104(1):51-6.
1991: Toni S Shippenberg; R Bals-Kubik; A Huber; A Herz
Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists.
Psychopharmacology 1991;103(2):209-14.
1990: Rainer Spanagel; A Herz; Toni S Shippenberg
Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens.
European journal of pharmacology 1990;190(1-2):177-84.
1990: Rainer Spanagel; A Herz; Toni S Shippenberg
The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study.
Journal of neurochemistry 1990;55(5):1734-40.
1990: R Bals-Kubik; Toni S Shippenberg; A Herz
Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat.
European journal of pharmacology 1990;175(1):63-9.
1989: C Stein; M J Millan; Toni S Shippenberg; K Peter; A Herz
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
The Journal of pharmacology and experimental therapeutics 1989;248(3):1269-75.
1989: Toni S Shippenberg; M W Emmett-Oglesby; A Herz
Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity.
Pharmacology, biochemistry, and behavior 1989;32(1):129-32.
1989: R Bals-Kubik; A Herz; Toni S Shippenberg
Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.
Psychopharmacology 1989;98(2):203-6.
1988: Toni S Shippenberg; C Stein; A Huber; M J Millan; A Herz
Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists.
Pain 1988;35(2):179-86.
1988: R Bals-Kubik; A Herz; Toni S Shippenberg
Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(4):392-6.
1988: Toni S Shippenberg; M J Millan; R F Mucha; A Herz
Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat.
European journal of pharmacology 1988;154(2):135-44.
1988: Toni S Shippenberg; A Herz
Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.
European journal of pharmacology 1988;151(2):233-42.
1988: M W Emmett-Oglesby; Toni S Shippenberg; A Herz
Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.
The Journal of pharmacology and experimental therapeutics 1988;245(1):17-23.
1988: C Stein; M J Millan; Toni S Shippenberg; A Herz
Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat.
Neuroscience letters 1988;84(2):225-8.
1988: Toni S Shippenberg; M W Emmett-Oglesby; F J Ayesta; A Herz
Tolerance and selective cross-tolerance to the motivational effects of opioids.
Psychopharmacology 1988;96(1):110-5.
1987: Toni S Shippenberg; R Bals-Kubik; A Herz
Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes.
Brain research 1987;436(2):234-9.
1987: Toni S Shippenberg; A Herz
Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.
Brain research 1987;436(1):169-72.
1987: Toni S Shippenberg; A Herz
Motivational properties of opioids.
Polish journal of pharmacology and pharmacy 1987;39(5):577-83.
1986: Toni S Shippenberg; A Herz
Differential effects of mu and kappa opioid systems on motivational processes.
NIDA research monograph 1986;75():563-66.